Alexander A. Parikh, MD, MPH, FACS, FSSO

Chief of Surgical Oncology in the Division of Surgical Oncology and Endocrine Surgery
UT Health San Antonio MD Anderson Mays Cancer Center

Poster(s):

• E199: Black Race and CA 19-9 Nonproduction is Associated with Limited Pathologic Response to Neoadjuvant Chemotherapy in Patients with Localized Pancreatic Cancer

• E215: Patient Expectations about the Oncologic Benefit of Surgery Among Patients Undergoing Pancreatectomy for Pancreatic Cancer

• E270: Decreased Primary Tumor Th2 Cell Tumor Infiltration is Associated with Liver Metastases Across Cancer Types

• E287: Trends in the Utilization of Neoadjuvant Therapy and its Impact on Vascular Resection Among Patients Undergoing Resection for Pancreatic Adenocarcinoma